Skip to main
MMSI

MMSI Stock Forecast & Price Target

MMSI Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 38%
Buy 38%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Merit Medical Systems is well positioned for future growth due to its focus on higher-growth therapeutic products, global reach, and comprehensive portfolio. With a new CEO at the helm and the company now in the final year of its Continued Growth Initiatives program, we expect to see continued revenue growth and margin expansion. The company's strong balance sheet and prudent M&A strategy also provide potential for future growth and value creation.

Bears say

Merit Medical Systems is struggling with declining revenues in its Cardiovascular segment and high levels of inventory, which have resulted in poor free cash flow conversion and lower operating margins. Although the company has seen some growth and expansion in recent years, there are concerns about their ability to sustain it in the long term, especially with their dependence on a single revenue-generating segment. The recent M&A activity may provide some short-term benefits, but the dilutive impact on 12-month price targets has lowered confidence in the company's overall outlook for long-term growth.

MMSI has been analyzed by 8 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 38% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Merit Medical Systems and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Merit Medical Systems (MMSI) Forecast

Analysts have given MMSI a Buy based on their latest research and market trends.

According to 8 analysts, MMSI has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $98.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $98.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Merit Medical Systems (MMSI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.